A 38 year old male has paroxysmal hypeension. He is subsequently found to have medullary carcinoma of the thyroid, pheochromocytoma, and mucosal neuromas. Parathyroid involvement is not noted. What is the most likely diagnosis?
**Core Concept**
The most likely diagnosis is Multiple Endocrine Neoplasia Type III (MEN III), a rare autosomal dominant disorder characterized by medullary thyroid carcinoma, pheochromocytoma, and mucosal neuromas, with no parathyroid involvement. It results from mutations in the **RET proto-oncogene**, though with a distinct pattern compared to other MEN syndromes.
**Why the Correct Answer is Right**
MEN III is caused by **RET gene mutations** and presents with **medullary thyroid carcinoma**, **pheochromocytoma**, and **mucosal neuromas** (especially in the oral and gastrointestinal tracts). Unlike MEN I or II, it does **not** involve parathyroid glands. The syndrome is typically associated with **late-onset** disease and is linked to **neuroendocrine tumors** arising from neural crest cells. The presence of all three features—medullary thyroid cancer, pheochromocytoma, and mucosal neuromas—without parathyroid involvement is highly specific for MEN III.
**Why Each Wrong Option is Incorrect**
Option A: MEN Type I involves **parathyroid adenomas**, **pituitary adenomas**, and **medullary thyroid carcinoma**—but **not mucosal neuromas**. Also, pheochromocytoma is rare in MEN I.
Option B: MEN Type II includes **medullary thyroid carcinoma**, **pheochromocytoma**, and **parathyroid adenomas** (in some variants), but **mucosal neuromas are absent**. It also occurs in early life and is associated with **MEN II-A and II-B**.
Option D: Sipple’s syndrome (also known as Multiple Endocrine Neoplasia Type II, or MEN II with syndromic features) includes **medullary thyroid cancer**, **pheochromocytoma**, and **mucosal neuromas**, but **parathyroid involvement is common**—contrary to the patient’s presentation.
**Clinical Pearl / High-Yield Fact**
MEN III is rare and primarily presents with **neuroendocrine tumors** without parathyroid involvement. It is often **diagnosed late** due to subtle symptoms and is linked to **RET gene mutations**—but unlike MEN I/II, it lacks parathyroid disease.
✓ Correct Answer: C. MEN type III